RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-761
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_0933500; Gene model (P.falciparum): PF3D7_1114100; Gene product: rhomboid protease ROM1 (ROM1)
Transgene
Transgene not Plasmodium: A fusion of GFP (gfp-mu3) and Luciferase Firefly (LucIAV)
Promoter: Gene model: PBANKA_1133300; Gene model (P.falciparum): PF3D7_1357100; Gene product: elongation factor 1-alpha (eef1a)
3'UTR: Gene model: PBANKA_0719300; Gene product: bifunctional dihydrofolate reductase-thymidylate synthase, putative (dhfr/ts)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (230p)
Phenotype Liver stage;
Last modified: 16 March 2013, 12:16
  *RMgm-761
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 23490234
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 676m1cl1 (RMgm-29)
Other information parent line676m1cl1 (RMgm-29) is a reference ANKA mutant line which expresses GFP-luciferase under control of a constitutive promoter. This reference line does not contain a drug-selectable marker (PubMed: PMID: 16242190).
The mutant parasite was generated by
Name PI/ResearcherJ. Lin; S.M. Khan; C.J. Janse
Name Group/DepartmentLeiden Malaria Research Group
Name InstituteLeiden University Medical Center (LUMC)
CityLeiden
CountryThe Netherlands
Name of the mutant parasite
RMgm numberRMgm-761
Principal name1496cl4
Alternative nameΔrom1-c
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteNot different from wild type
Liver stageLiver-stage development was reduced as shown by a 1-day extension of the prepatent period in mice following the inoculation with 10(4) purified sporozoites.
While gliding motility and the rate of cell traversal of sporozoites were similar to wild type parasites, in two out of three experiments a reduction in sporozoite in vitro invasion rates was observed that could explain (in part) the delay in the prepatent period. Immunofluorescence analyses of liver stage parasites stained with antibodies against markers for parasite development (HSP70), PVM (UIS4 and EXP1) and merozoite formation (MSP1), revealed no distinct differences in morphology and size between ∆rom1 and wild type liver stages at 24h or 48h after sporozoite invasion.
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of the rhomboid protease ROM1.

Protein (function)
Rhomboid proteins are intra-membrane proteases that play a role in multiple processes. They belong to a family of serine proteases that cleave cell-surface proteins within their transmembrane domains. The Plasmodium genome encodes a total of 8 rhomboid proteases (ROM1, 3, 4, 6, 7, 8, 9 and 10). ROM1 is expressed in both the blood stages and mosquito stages (sporozoites). ROM1 was localized to organelles of the apical complex of merozoites. In vitro substrates of P. falciparum ROM1 include the merozoite-specific proteins AMA1 (apical membrane antigen 1) and proteins of the EBL (erythrocyte binding ligands) and RBL (reticulocyte binding ligands) families as well as several proteins of the invasive ookinete- and sporozoite-stages, such as TRAP (thrombospondin-related anonymous protein), CTRP (circumsporozoite- and TRAP-related protein) and MAEBL (merozoite adhesive erythrocytic binding protein).
In P. falciparum only a small fraction of AMA1 is shed by ROM1 and the intramembrane cleavage can be reduced to undetectable levels by mutagenesis without discernible phenotypic consequences. The successful generation of P. berghei and P. yoelii mutants that lack expression of ROM1 (see below) also demonstrates that ROM1 is not essential for blood stage multiplication

Phenotype
The phenotype analyses indicate that ROM1 is not essential throughout the complete life cycle in P. berghei.
Liver-stage development was reduced as shown by a 1-day extension of the prepatent period in mice following the inoculation with 10(4) purified sporozoites.
While gliding motility and the rate of cell traversal of sporozoites were similar to wild type parasites, in two out of three experiments a reduction in sporozoite in vitro invasion rates was observed that could explain (in part) the delay in the prepatent period. Immunofluorescence analyses of liver stage parasites stained with antibodies against markers for parasite development (HSP70), PVM (UIS4 and EXP1) and merozoite formation (MSP1), revealed no distinct differences in morphology and size between ∆rom1 and wild type liver stages at 24h or 48h after sporozoite invasion.

Additional information
It has been reported that P. berghei and P. yoelii mutants lacking ROM1 (see mutants RMgm-176, RMgm-659) exhibit a slight growth delay and appear less virulent in mice than wild type parasites. In contrast, the ∆rom1 mutant described here and in RMgm-177 neither a growth nor a virulence-attenuation phenotype have been detected. Mice infected with ∆rom1 parasites showed a normal course of infection and all C57BL/6 mice developed clear signs of experimental cerebral malaria (ECM). The cause for these discrepancies in blood stage phenotypes between the ∆rom1 P. berghei mutants described here and in RMgm-177 and the mutant RMgm-176 is unknown. In RMgm-176 the mutant clone examined was derived from a single transfection experiment.
Although a significant reduction in expression of UIS4 has been reported for liver stages of P. yoelii mutants lacking expression of ROM1 (RMgm-659), the ∆rom1 parasites showed only a slight, but not significant, reduction in liver-stages as determined by UIS4 staining and the liver stages of the ∆rom1 mutant had no unusual parasitophorous vacuole membrane as reported for the P. yoelii mutants. Liver stages of ∆rom1 and wild-type parasites were also comparable in size at 48 hrs post infection.

Other mutants
RMgm-176: A P. berghei mutant lacking expression of rhomboid protease ROM1 (partial disruption)
RMgm-177: A P. berghei mutant lacking expression of rhomboid protease ROM1 (partial disruption)
RMgm-178: A P. berghei mutant lacking expression of rhomboid protease ROM3
RMgm-762: A P. berghei mutant lacking expression of rhomboid protease ROM9
RMgm-179: A P. berghei mutant lacking expression of rhomboid protease ROM10

RMgm-187: Unsuccessful attempts to disrupt P. berghei rhomboid protease rom4
RMgm-758: Unsuccessful attempts to disrupt P. berghei rhomboid protease rom6
RMgm-759: Unsuccessful attempts to disrupt P. berghei rhomboid protease rom7
RMgm-760: Unsuccessful attempts to disrupt P. berghei rhomboid protease rom8

RMgm-763: A P. berghei mutant expressing a (C-terminal) GFP-tagged version of rhomboid protease ROM3
RMgm-764: A P. berghei mutant expressing a (C-terminal) mCherry-tagged version of rhomboid protease ROM4

RMgm-659: A P. y. yoelii 17XNL mutant lacking expression of rhomboid protease ROM1
RMgm-660: A P. y. yoelii 17XNL mutant expressing a (N-terminal) HA-tagged version of rhomboid protease ROM1


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0933500
Gene Model P. falciparum ortholog PF3D7_1114100
Gene productrhomboid protease ROM1
Gene product: Alternative nameROM1
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct usedPlasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Click to view information
Click to hide information
Plasmid/construct sequence
Click to view information
Click to hide information
CGATAAGCTTGCATGCCTGCAGGTCAACAATAAATAATAAATAAATATTGTGGAAATAAA
ATAACATATAATTATTTTTAATACATTGATTTCCCTTTTATTTTTTTAAATTTCATTGAT
ATAAAAATATATAATAATAACATATATGATTTCAAATTAATCTTTTCAAAAATGGTGTTT
ATTTTTGTATGTTTGTGTATGAATTAATCACATAACACATCTATTAAATTGAGTTGGTAA
TATAGACACAAATAAATATATATATTTTTATAGCTTAAAAGTGTGTTATGAATATTTTAA
GCATATTTTCTTTTTCTTTGGATTGTGTAAAATGAACTCATATAATGCGTTTTTTTGTTT
TTGTTATTTTGTCATTTTGTTATTTTGCTATTTTATGGATTAATTTTTGTTTATAAAATG
GGAAATAATTTTAACATATTTAAATAAATGGAGAAAAAATATAAAATAATTATAAAAAAA
AGTTAATACACATTTTTTCCTGTTATAGACCTTATATTTATTTATCCATATATATATATA
TATATATATATATATATATATACATACCAAGTGAATTAAGAGGAAAGCTAATTTATTATT
CAGAATAATATATGAACTATATATAATTTTTATTATTTTGGTGTATATTAATCTGTCTAT
ATGCATACATGCAATAATTTATCGACTTATATATCAAATAACATAAAATAGAAGTGTTTT
AAATTATGGATATATGCTCAATATTCATTTTTTTTAATAAGTTAGCTATATTTAAATTAT
ACATTTTATATATGGTCTCTTTTTTTTTTAAATATTATTTAAGTGATCATGAAAATATAA
ATAATTTTTTTTTATTTAATATCCTTTTGCTTGCATGTGGTAAATGGAAATTTGGATGTG
TTTTGAARGTTCGGATATAGTTGTATGGACATATAATATATTTTGTGAAAAATTGGTTTT
ATGTTTATACTTATGCCAATACTTTTTGAGTAAAACAAAGCAAGTGCTTATAAATAATTA
AAGCCAATTTTATAATATATATTTTTTTATTTAATTTGAATTTAGTAGTATAATTTTTTA
TGGTAAGTGCTCAAAGAGAGTTGCTTATAAAGTATGGTTTGTTTCTTTTTCGCCATTTTG
AATTACACATTAAAAATATATAGATACATATATTATAATATGAAATCATTAATAATTTAG
GGAAATTCTACAAATTTAAAAACGAATAAAATAATTGTTTTTCATCATGCCATAACACAA
TATTGATATATACATGTACAAACATTTTTTTTATTTGGAAAATATAAATTATATAAAAAA
AAATGTATAGTATACAAAATGAGCATATTCACACGGGGTGGACGTTCATTTTTTCATTTT
TCCCCTGTTTTTTATGAGTATATGATAAAATTTTATGAACATTTACACAAAATGAAAATG
GATATATAGGAAAAATGGAGCGGTATTTCATTTATCTTTGATTGTCATTTGGATATTATA
TTACCYTGGGTAGGCAATTAAAAATGTTAAATAACAATTTAAGGAAATTATATTTTATAT
ATTAAAATTAACACTGTATTATATGATTCGCTTATAAAAGCCACTCTTTCCCCATGCAAA
GCTGTTTAATATCAATTTTAACAAATTACACACATGTTAATATATTTATATATATAATTT
ATATATTTATAATTTATATATTTATATTTTTATTATTTATATATTTATTATTTATTGTGT
GTGTCAATTCGGGTAGGATATACCTCTTTTTTATTGTTTAAAGCGATTTGTATTCTAAAA
TATAAAGRATTTGAAAAAGAGAAAGATAGAATATGATCCCATCATATATAGCCCTATAAT
TTTTATTTAGCAGCGAATTAATTTTTCTATTAAGTTTATGTGTAATTAAAATAACGGAAT
ATATATAATACAATAAAAAAGTGCATAAATTAAAATTTTTTCAATTAAATTTTTTTTTTT
AAGGGGTTATATAATATTAAATATATAAAATACGATTATATATTTTTGCTACAATTTTTT
ATATTAAGATATAAATAGTAAATAAATGGTATTATATGGCATGTAATATATAAATTTTTT
CCAATTTTTATTTTATATACACTTTTCCTTTTTTTGTCATAAAACTTAAACAATTTACAC
ATTCATTTTAAAAATTGACTATTTGTTTCAACATTTTTTGAGTTTCCGTTTTATAATAGT
ATTTTCATTTGTATATTGCTTATATATATAAATACACACCTAAATGTTACAAAGGATCAA
TGCATAAACCGGTGTGTCTGGTCGTCGCGATGACCCCCAAGAGGGGCATCGGCATCAACA
ACGGCCTCCCGTGGCCCCACTTGACCACAGATTTCAAACACTTTTCTCGTGTGACAAAAA
CGACGCCCGAAGAAGCCAGTCGCCTGAACGGGTGGCTTCCCAGGAAATTTGCAAAGACGG
GCGACTCTGGACTTCCCTCTCCATCAGTCGGCAAGAGATTCAACGCCGTTGTCATGGGAC
GGAAAACCTGGGAAAGCATGCCTCGAAAGTTTAGACCCCTCGTGGACAGATTGAACATCG
TCGTTTCCTCTTCCCTCAAAGAAGAAGACATTGCGGCGGAGAAGCCTCAAGCTGAAGGCC
AGCAGCGCGTCCGAGTCTGTGCTTCACTCCCAGCAGCTCTCAGCCTTCTGGAGGAAGAGT
ACAAGGATTCTGTCGACCAGATTTTTGTCGTGGGAGGAGCGGGACTGTACGAGGCAGCGC
TGTCTCTGGGCGTTGCCTCTCACCTGTACATCACGCGTGTAGCCCGCGAGTTTCCGTGCG
ACGTTTTCTTCCCTGCGTTCCCCGGAGATGACATTCTTTCAAACAAATCAACTGCTGCGC
AGGCTGCAGCTCCTGCCGAGTCTGTGTTCGTTCCCTTTTGTCCGGAGCTCGGAAGAGAGA
AGGACAATGAAGCGACGTATCGACCCATCTTCATTTCCAAGACCTTCTCAGACAACGGGG
TTCCCTACGACTTTGTGGTTCTCGAGAAGAGAAGGAAGACTGACGACGCAGCCACTGCGG
AACCGAGCAACGCAATGAGCTCCTTGACGTCCACGAGGGAGACAACTCCCGTGCACGGGT
TGCAGGCTCCTTCTTCGGCCGCAGCCATTGCCCCGGTGTTGGCGTGGATGGACGAAGAAG
ACCGGAAAAAACGCGAGCAAAAGGAACTGATTCGGGCCGTTCCGCATGTTCACTTTAGAG
GCCATGAAGAGTTCCAGTACCTTGATCTCATTGCCGACATTATTAACAATGGAAGGACAA
TGGATGACCGAACGGGCGTTGGTGTCATCTCCAAATTCGGCTGCACTATGCGCTACTCGC
TGGATCAGGCCTTTCCACTTCTCACCACAAAGCGTGTGTTCTGGAAAGGGGTCCTCGAAG
AGTTGCTGTGGTTCATTCGCGGCGACACGAACGCAAACCATCTTTCTGAGAAGGGCGTGA
AGATCTGGGACAAGAATGTGACACGCGAGTTCCTCGATTCGCGCAATCTCCCCCACCGAG
AGGTCGGAGACATCGGCCCGGGCTACGGCTTCCAGTGGAGACACTTCGGCGCGGCATACA
AAGACATGCACACAGACTACACAGGGCAGGGCGTCGACCAGCTGAAGAATGTGATCCAGA
TGCTGAGAACGAATCCAACAGATCGTCGCATGCTCATGACTGCCTGGAATCCTGCAGCGC
TGGACGAAATGGCGCTGCCGCCTTGTCACTTGTTGTGCCAGTTCTACGTGAACGACCAGA
AGGAGCTGTCGTGCATCATGTATCAGCGGTCGTGCGATGTCGGCCTCGGCGTCCCCTTCA
ACATCGCTTCCTATTCGCTTTTGACGCTCATGGTTGCACACGTCTGCAACCTAAAACCTA
AGGAGTTCATTCACTTCATGGGGAACACGCATGTCTACACGAACCATGTCGAGGCTTTAA
AAGAGCAGCTGCGGAGAGAACCGAGACCGTTCCCCATTGTGAACATCCTCAACAAGGAAC
GCATCAAGGAAATCGACGATTTCACCGCCGAGGATTTTGAGGTCGTGGGCTACGTCCCGC
ACGGACGAATCCAGATGGAGATGGCTGTCTAGCGGAAATACAGAAGCTAGCTTTGATCCC
GTTTTTCTTACTTATATATTTATACCAATTGATTGTATTTATAACTGTAAAAATGTGTAT
GTTGTGTGCATATTTTTTTTTGTGCATGCACATGCATGTAAATAGCTAAAATTATGAACA
TTTTATTTTTTGTTCAGAAAAAAAAAACTTTACACACATAAAATGGCTAGTATGAATAGC
CATATTTTATATAAATTAAATCCTATGAATTTATGACCATATTAAAAATTTAGATATTTA
TGGAACATAATATGTTTGAAACAATAAGACAAAATTATTATTATTATTATTATTTTTACT
GTTATAATTATGTTGTCTCTTCAATGATTCATAAATAGTTGGACTTGATTTTTAAAATGT
TTATAATATGATTAGCATAGTTAAATAAAAAAAGTTGAAAAATTAAAAAAAAACATATAA
ACACAAATGATGTTTTTTCCTTCAATTTCGATATCGAATTCAAGTTATAGTAAATATGCT
TTGCTCCAAATATATATATATATATGCCCATTTTGGCATATATATATAAAACATTTATTC
CGCACATAGTAAGCGACCATTTACACACCTATATGATTAATAGATTCGAAATCCATACAA
TAAAAATTTAATGAATTATAATAATATTAAAAACACATGCATATTCTTTAATTTGCTCCT
TTAATTTTTTATAACCATTTTTTAATTTCTAATAATGATAACAATAGTAACAATTTTTTA
AGTTATTATATTTATTTACCATAGTTTTTTCATTTATTCTCTTTTTCTTGTATTTTTGTA
TTGCCCTTTTTTGTTAAATTTTAAATATACAGAAAAAAAAAACTTTTTTTTTAATTTAAA
TATATACATAACTATAAATATATTTGTGGACACATAATTTAATTAATAAATTTGAAAAGT
TAAAACCACATTTAAGCACAGCGTATATGTCGTTATTTTTTTAACATGTTTTCTATGAGT
TATGTTTTCTTTTGTGTTGTTTTAAAAATATGTATATCAAAATCAATAATAGACAAGCCA
GTTTATTAAACTAGACTCAACGATATATTTAAAAAATATTAAAGCTAAAAAATTATTTAA
AAATATTAAATAATTTCATTTTTACAAAATAAGTTGATTTTGTTAAGAATACTATTTAAA
AATTAAATAATCATCGAATATTTGTTTTTTCCATTGTTACATCGAGATATTTTTTCATTA
AACAAACGAAAATATTTATAACTTAAAAAATTATAATATAAAAAAAATAAAACGACAAAA
AAAACAAATAAAAATCGGTACAAAGATATATACATAGGGGATCCACTAGTTCTAGAGCGG
CCGCCACCGCGGTGGAGCTCCAATTCGCCCTATAGTGAGTCGTATTACAATTCACTGGCC
GTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCA
GCACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAAGAGGCCCGCACCGATCGCCCTTCC
CAACAGTTGCGCAGCCTGAATGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCG
GCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCT
CCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTA
AATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAA
CTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCT
TTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTC
AACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGG
TTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAAATATTAACGCTT
ACAATTTAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGTTTATTTTTCT
AAATACATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAAT
ATTGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTG
CGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTG
AAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGATCC
TTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTAT
GTGGCGCGGTATTATCCCGTATTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACT
ATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCA
TGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCAACT
TACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGG
ATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACG
AGCGTGACACCACGATGCCTGTAGCAATGGCAACAACGTTGCGCAAACTATTAACTGGCG
AACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAGTTG
CAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAG
CCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCC
GTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGA
TCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAAGTTTACTCAT
ATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAAAAGGATCTAGGTGAAGATCC
TTTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAG
ACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCT
GCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTAC
CAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTC
TAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCG
CTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGT
TGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGT
GCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGC
TATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCA
GGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATA
GTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGG
GGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCT
GGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTA
CCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAG
TGAGCGAGGAAGCGGAAGAGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGA
TTCATTAATGCAGCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACG
CAATTAATGTGAGTTAGCTCACTCATTAGGCACCCCAGGCTTTACACTTTATGCTTCCGG
CTCGTATGTTGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTATGACC
ATGATTACGCCAAGCTCGAAATTAACCCTCACTAAAGGGAACAAAAGCTGGTACCTATCG
AGCAACAATGTCTGACAAGGGTGAAAAAAAAATTTACATGCGTCAGTTATTTGTTTATTT
TTTTTATTTTTTTTATTTTTATTTTAATTCTTTTTATTTATTTAATAGTCTTTTGCCCAA
TTAATCATAAATAATAAATCTTCATAAAAAATTTATTATATATATATGTATATTGTATAT
TATAAATTTAAATGAAATTGGGATTAATTAAATAAGCTTCCGAAAATTTTATACAATTAG
CCACTTCACACACATAATAGTATATTTTTATAATGCATATAATTTTGTAGATTACTTAAA
TCAAGGTTCTTTTTTTTTCTTTTTCTTTTTGTGTCCTGATTTATATTTATATTTTCATTT
GTACTTAATTATATTATATATACTAATAATGTTATCGCTTTGTGCCTATTTCATTCTTTA
TTCATTTTTTTAATTAATATTATTGGTACGAGAGTTTGATTATACTAATTATGCATTGTA
TAACATCTCTGTTTTTTTATTTACACATTTTATATTTATATATATATATATAATATTCGT
TGTGAATATAATCAGGAAATAATATATACACACAATTATTACACATATATAGTATATATA
TGCCACATATATGCTTTGAGTTTGGACTTATTTAT
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1GACGGGTACCTATCGAGCAACAATGTCTG
Additional information primer 14718 (Asp718I); 5’- rom1 targeting region F
Sequence Primer 2CCCATCGATAAATAAGTCCAAACTCAAAGC
Additional information primer 24937 (ClaI); 5’- rom1 targeting region R
Sequence Primer 3CCGGAATTCAAGTTATAGTAAATATGCTTTGC
Additional information primer 34697 (EcoRI); 3’- rom1 targeting region F
Sequence Primer 4TTGGATCCCCTATGTATATATCTTTGTACCG
Additional information primer 42087 (BamHI); 3’- rom1 targeting region R
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameA fusion of GFP (gfp-mu3) and Luciferase Firefly (LucIAV)
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/constructPlasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitegfp (FACS)
Promoter of the selectable markereef1a
Selection (positive) procedureFACS (flowsorting)
Selection (negative) procedureNo
Additional remarks genetic modificationThe GFP-Luciferase gene (1 copy) has been inserted into the 230p locus by double cross-over integration.
Additional remarks selection procedureThis reporter mutant expressing GFP-Luciferase does not contain a drug-selectable marker. This mutant has been selected by FACS sorting after transfection based on GFP fluorescence.
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1133300
Gene Model P. falciparum ortholog PF3D7_1357100
Gene productelongation factor 1-alpha
Gene product: Alternative nameeef1a
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_0719300
Gene productbifunctional dihydrofolate reductase-thymidylate synthase, putative
Gene product: Alternative namedhfr/ts
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative name230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4